The Enhancing Oncology Model (EOM) is a voluntary, patient-centered healthcare payment model developed by the Centers for Medicare & Medicaid Services (CMS) to improve cancer care delivery and outcomes while reducing costs.
Sponsors considering using data from sensors and wearables in their clinical trials worry about three scenarios: collecting too little data, collecting too much data, and collecting bad data. Each outcome could likely impact their study or a portion of it with a significant waste of time, money, and patient goodwill.
The Three Perils of Wearable Data Read More...
We all benefit from many technological advances—from GPS to AI/ML to ChatGPT—without questioning exactly how they work. There’s no real need to understand what goes on “behind the curtain” or “under the hood.” The focus is on what is created over how output and results are created.
Debunking Complex Data Preparation and Analysis Read More...
There’s a single word that captures the spirit of business since the start of the pandemic: “direct.” Brands are adopting direct-to-consumer models wherever possible to trim time and costs from the distribution chain. And it’s not that different in the data world. “Direct” is the catchword of the day.
Straight from the Source: How Capturing Data Directly is Transforming Trials Read More...
Imagine if someone were to give you hours more time in your day. Most people would gladly take it. In essence, that’s what eSource technology offers investigator sites — 30 percent more time to spend on patient care.
eSource Technology: An “Easy Sell” to Clinical Trial Sites Read More...
As Sponsors incorporate eSource technologies and decentralized data collection into their trials, barriers to patient participation and adherence are beginning to fall away.
eSource: Power to the Patient Read More...
When electronic data capture (EDC) systems came onto the clinical trial scene, no one expected them to…
eSource: The Future of Real Time Data Capture and the Departure from EDC Read More...
New Positions Created to Manage Dramatic Growth HORSHAM, Pa.; May 4, 2021 – Clinical Ink, a global clinical trial technology company, today announced the hiring
Clinical Ink Hires CCO Chris Crucitti, COO Brian Donahue, VP Bill Barrasso Read More...
In late September, the EMA released an important qualification opinion in favor of using eSource direct data capture (DDC) in clinical trials. The EMA’s opinion
EMA Greenlights eSource DDC and References Clinical ink Read More...
eSource and IRT Integration Simplifies the Site Experience SAN FRANCISCO, CA & PHILADELPHIA, PA – May 18, 2017 Endpoint Clinical, the leading global interactive response technology
Clinical ink and endpoint Announce ‘Industry-First’ Alliance Read More...
Sales and Solutions
Direct 1.336.464.0697
Support
Toll-Free 1.800.301.5033
Direct 1.336.464.0697
Insert HTML text here.
Request more information, submit questions, set up a demonstration, and more.
